New Key Statistics Module, Z-Score and F-Score
NAS:PRME Key Ratios
Market Cap $ M | 803.00 |
Enterprise Value $ M | 628.87 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.30 |
Price/Sales | 1,074.83 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.18 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.15 |
EV-to-EBITDA | -3.23 |
PEG | -- |
Shares Outstanding M | 120.03 |
Net Margin (%) | -34,601.86 |
Operating Margin % | -33,773.27 |
Pre-tax Margin (%) | -34,592.22 |
Quick Ratio | 8.91 |
Current Ratio | 8.91 |
ROA % (ttm) | -76.18 |
ROE % (ttm) | -93.83 |
ROIC % (ttm) | -246.16 |
Dividend Yield % | -- |
Altman Z-Score | 3.00 |
PRME Number of Guru Trades
PRME Volume of Guru Trades
Gurus Latest Trades with NAS:PRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRME is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Prime Medicine Inc Insider Transactions
No Available Data
News about NAS:PRME
Total 0- 1